Market Research Report : Pharmacy retail market in india 2015 - Sample

June 2, 2016 | Author: Netscribes, Inc. | Category: N/A
Share Embed Donate


Short Description

For the complete report, get in touch with us at: [email protected] Abstract : Netscribes’ latest market res...

Description

Pharmacy Retail Market – India July 2015

Executive Summary Market

Drivers & Challenges

Trends

 The Indian pharmacy retail market is currently valued at INR x bn and is estimated to reach INR y bn by 2019  The market is distinctly fragmented into organized and unorganized players with ~x% of the market being dominated by the unorganized segment in 2014

Drivers

Challenges

 Loyalty Schemes  Value Added Services  Entry of Government in Pharmacy Retailing  Organized Retailers Starting Pharmacy Chains  Entry of Private Labels

 Rural Expansion  Health Insurance Plans made available in pharmacies  Tracking of Counterfeit Drugs

 Growth in Pharmaceuticals Sector  Rising Healthcare Expenditure  Changing Disease Profile  Growth in OTC Segment  Consumer Attitude  Attractive Margins

 Capital Intensive Business  Fragmented Industry  Counterfeit Drugs

Key Players

Competitive Landscape

Company A

Company B

Company C

Company D

Company E

Company F

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

2

•Macroeconomic Indicators •Introduction

•Market Overview •Drivers & Challenges •Key Trends •Government Regulations •Industry Association •Technology Adoption •Competitive Landscape •Strategic Insights •Appendix PHARMACY RETAIL MARKET IN INDIA 2015.PPT

3

Macroeconomic Indicators (3/3) Lending Rate: Annual x

x

x

x

x

Trade Balance: Annual x

x

x

x

x

x

x

% Per Annum INR tn

x

x

2011-12 x

x x x

x

x

x

x

x 2012-13

2011-12 2012-13 N.B.: 2012-13 encompasses figure for Apr2013-14 – Nov 2012

x

2014-15

FDI: Annual x 2013-14 x

INR bn x

x

x

2014-15 x

x

x

x

2012-13

2013-14

x

x Min

Max

Commercial Bank Rates: Key Lending Rates as Prescribed by RBI (All Commercial Banks including SBI) - Minimum Rate General

x 2010-11

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

2011-12

4

Healthcare system in India requires a larger public outlay due to the huge population base Healthcare Industry Overview

Healthcare Sector – Market Size & Growth

• Indian healthcare industry contributes ~x% to the Gross Domestic Product (GDP) and was estimated to be valued at INR x tn in 2014 • Favorable demographics, increase in awareness levels, improvement in medical insurance penetration, better medical care are some factors that are driving the healthcare sector in India • Hospitals form the largest segment of overall healthcare market, followed by pharmacy, medical equipments, diagnostics and thereafter, medical insurance • Gradual penetration of health insurance is stepping up affordability of health services through increased demand for preventive and curative healthcare services • Superior quality healthcare, coupled with low treatment cost in comparison to other countries, is benefitting Indian medical tourism, thereby steering forth Indian healthcare market

tn x x x

x

x

x

x

x

2013

2014

2015e

x x

x

0 2016e

2017e 2018e 2019e

Market Segmentation – Overview (2013) Hospital

x

x

Pharmaceutical Medical Devices

x x

Diagnostics

x

 Treatment for major surgeries in India costs approximately x% of that in developed countries

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

Health Insurance Others

x

5

FDI Inflow into Indian Healthcare Segments Several healthcare segments in India have earned good volume of FDI over a 14- year span between Apr 2000 to Feb 2014

Drugs and pharmaceuticals sector

INR x bn

Hospital and diagnostic centers

INR x bn

Medical and surgical appliances

INR x bn

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

6

Disparity in income levels across population strata results in income elasticity of demand for healthcare Healthcare Expenditure of Population by Economic Standard Top 10% Population

Medicine

Doctor/ Surgeon’s Fees

Medical Diagnostics

Hospital/ Nursing Home Fees

x

Middle 40% Population

Bottom 50% Population

x

x

x

x

x

x

x

x

x

x

x

• Private healthcare spending is highly disparate for top x% and bottom x% population strata, which gets even more pronounced in cases of medical diagnostics and hospitalization • According to recent statistics, income elasticity of demand for healthcare is over x N.B.: Data as per NSSO 2011 PHARMACY RETAIL MARKET IN INDIA 2015.PPT

7

Pharmacy retail has become the fastest growing traditional trade channel for FMCG companies Pharmacy Retail – Market Overview (1/2) • Indian pharmacy retail stands out as a lucrative market that still remains underpenetrated, projecting strong potential • Growth of pharmaceutical sector has a direct impact on pharmacy retail sector which is the major sales format apart from institutional sales • Currently the pharmacy retail market in India has over x pharmacy retail outlets and more than x stockists/distributors • Pharmacy retail chains have become preferred trade partner for consumer product companies and FMCG contributed around 9% to the overall pharmacy retailers revenue in 2014

Market Size and Growth

Market Segments – 2014

INR bn

x

x

x

x

x

x x

x

x

x

x

x x

x

x

0 2013

2014 2015e 2016e 2017e 2018e 2019e

Pharmaceutical Contribution

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

FMCG Contribution

8

Unorganized segment dominates a large volume of the pharmaceutical retail market Pharmacy Retail – Market Overview (2/2) • The unorganized market is huge and is roughly valued at INR x bn occupying x% of the total market size in 2014  The unorganized pharmacy retail market is growing at a CAGR of x% while organized pharmacy retail is expected to grow at a CAGR of x%  There should be a significant change in the market segmentation by 2019 when organized retail will capture approximately x% market from the current x% share  Health awareness among consumers will result in gradual shift towards the modern pharmacy retailers

• In India, pharmacies are the dominant distribution channels generating ~x % of overall pharmaceutical sales

Organized Market Size and Growth

Unorganized Market Size and Growth

INR bn

INR bn

x

x

x x x

x x

x

x x 0

x

x

x x

x

x

x x

x

x

x

x

x

x

x x

x 0

2013

2014 2015e 2016e 2017e 2018e 2019e

2013

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

2014 2015e 2016e 2017e 2018e 2019e

9

Drivers & Challenges

Drivers Growth in Pharmaceuticals Sector

Challenges

Rising Healthcare Expenditure

Capital Intensive Business

Changing Disease Profile

Fragmented Industry

Growth in OTC Segment

Counterfeit Drugs

Consumer Attitude Attractive Margins

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

10

Growing Indian pharmaceutical industry stimulates the pharmacy retail market Growth in Pharmaceuticals Sector

Impact

• XX • XX • XX • XX • XX

Pharmaceutical Market Size and Growth

INR bn x x x

x

15.7%

x

x

x

2013

2014

2015e

x

x

x

x 0 2016e

2017e

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

2018e

2019e 11

Rise in chronic diseases is driving growth of pharmaceutical sector, thus promoting the pharmacy retailing business Changing Disease Profile

Impact

• The disease profile in India is changing from infectious diseases to lifestyle-based diseases, which requires more intensive care • The incidences of lifestyle-based diseases has increased with changing lifestyle  India is home to a large number of heart disease, stroke, cancer, diabetes and respiratory infection affected patients  Stress, sedentary lifestyles and unhealthy food habits are key reasons for the growing number of patients who suffer from lifestyle-based ailments that are of long duration and slow progression

• This will entail medication on an ongoing basis, which in turn will make prescription-based medicines mandatory for expansion of the pharmacy retail business in India Diabetes Patient – India

Cancer Patient – India ‘000

mn

x

x x

x

x

x

x

x

x

x x

x

x x

x

0 2012 2013e 2014e 2015e 2016e 2017e 2018e

x

x

x

x

Male Femalee

2013

2020e

• As of Apr 2015, Chronic diseases account for ~x% of all deaths in India • These diseases will cost India ~INR x tn between 2012 and 2030 in terms of economic output PHARMACY RETAIL MARKET IN INDIA 2015.PPT

12

Pharmacy retail business is a capital intensive proposition that involves strategic location of outlets Capital Intensive Business

Impact

• Pharmacy retailing is a capital intensive business proposition and stands out as a catchment specific business Pharmacy Retail Business – A Catchment Specific Business Success Involves Proximity To

Hospital area

Commercial area

Spells burden on the business operators due to prohibitive real estate cost in such areas • Pharmacy retail in today’s scenario essentially involves store expansion and its multiplication  Each store involves an approximate cost of

 Each store requires minimum

to set up and start operation

to breakeven PHARMACY RETAIL MARKET IN INDIA 2015.PPT

13

Key Trends

Loyalty Schemes Value Added Services Entry of Government in Pharmacy Retailing Organized Retailers Starting Pharmacy Chains

Trends ` Entry of Private Labels Rural Expansion Health Insurance Plans Made Available in Pharmacies

Tracking of Counterfeit Drugs

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

14

Introduction of private labels by organized retailers pushes their business Entry of Private Labels • Some retail chains are now getting generic drugs, such as paracetamol, contract-manufactured by licensed third-parties and then marketing them under their own brand-names Private labels to provide low cost alternative medicines

Company A • XX • XX • XX • XX

Company B • XX • XX • XX Attractive Pricing – Private Label Brands X

X

X

Currently, Organized Pharmacy Retailer’s private label portfolio comprises X% of their overall products PHARMACY RETAIL MARKET IN INDIA 2015.PPT

15

Government Role: Summary

Licence Procurement

Role of Government

Foreign Direct Investment

Ownership Restrictions

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

16

All India Organization of Chemists and Druggists (AIOCD) •XX •XX Initiatives to Organize the Unorganized Segment of Pharmacy Retail The Organization with its members have decided to go for a common brand name, logo and color code

There are plans to open new shops for members that will be inter-connected electronically, using common branding

• XX • XX • XX • XX

The association has hired brand consulting firm Chlorophyll for ‘Chlorophyll’ forbrand-building brand-buildingexercise exerciseand andproviding providingITIT support to chemists and back-end processes, which is expected to bring down costs significantly

•X

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

17

Technology Adoption: Summary

Customer Relationship Management

Technology Trends

Supply Chain Management

Enterprise Resource Planning

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

18

Porter’s Five Forces Analysis Impact X Threat of New Entrants •X

Impact X

Impact X Impact X

Bargaining Power of Suppliers •X

Competitive Rivalry

Bargaining Power of Buyers •X

•X

Impact X Threat of Substitutes •X

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

19

Competitive Benchmarking (3/3) Key Ratios of Top 3 Companies – Operational Basis (FY 2014) (3/3) Debtors Turnover Ratio 2012

Asset Turnover Ratio

2014

x

x

x

2013

x

x

x

x x

x

x

x x

0

0 Emami Frank Ross Ltd.

RWL Healthworld

x

x x x Emami Frank Ross Ltd.

RWL Healthworld

The Himalaya Drug Company

• XX • XX • XX

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

20

Public: Domestic Company – Company A (1/4) Company Information

Corporate Address

XX

Tel No.

XX

Fax No.

XX

Website

XX

Year of Incorporation

XX

Ticker Symbol

XX

Stock Exchange

XX

Offices and Centres – India

Head Office Chennai

Products and Services Category

Products/Services

XX

XX

XX

XX

Key People Name

Designation

XX

XX

XX

XX

XX

XX

XX

XX

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

21

Public: Domestic Company – Company A (2/4) Financial Snapshot Total Revenue

INR bn 60 40 20

1.84 26.05

2.19 31.48

Key Ratios Net Profit / Loss 3.04

37.99

INR bn

3.17

43.84

0

4 2 0

Particulars

2011

2012

2013

2014

Gross Margin %

30.6%

31.4%

31.7%

31.2%

Net Income Margin %

7.10%

7.00%

8.00%

7.20%

EBITDA Margin %

16.20%

16.50%

17.00%

15.30%

Profitability Ratios

EBITA Margin %

0.13

0.13

0.13

0.12

EBIT Margin %

12.60%

12.70%

13.20%

11.60%

Financial Summary

Return on Assets %

6.00%

6.50%

7.10%

6.20%

• The company earned a net profit of INR 3.17 bn in FY 2014, as compared to net profit of INR 3.04 bn in FY 2013

Return on Working Capital %

7.5%

8.0%

8.7%

7.7%

Return on Equity %

10.1%

9.8%

11.5%

11.0%

Current Ratio

1.39

1.46

2.12

1.88

Cash Ratio

0.96

1.04

1.60

1.20

Total Debt/Equity

0.50

0.32

0.41

0.45

Total Debt/ Working Capital

0.33

0.24

0.29

0.31

Interest Coverage

4.45

4.95

5.51

4.74

2011

2012

2013

2014

• The company reported total revenue of INR 43.84 bn in FY 2014, registering an increase of 15.4 % over FY 2013 • The company earned gross margin of 31.2 % in FY 2014, as compared to 31.7% in 2013 • The company reported debt to equity of 0.45 in FY 2014, as compared to 0.41 in 2013

Financial Summary

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Indicators

Value (08/07/2015)

Total Asset Turnover

0.76

0.82

0.86

0.86

Market Capitalization (INR mn) Total Enterprise Value (INR mn) EPS (INR) PE Ratio (Absolute)

181,328.8 194,967.9 N.A. N.A.

Fixed Asset Turnover

1.55

1.63

1.64

1.58

Accounts Receivable Turnover

9.95

9.16

8.76

8.83

Inventory Turnover

12.06

12.34

12.65

12.14

Note: Parent Company Financials

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

22

Public: Domestic Company – Company A (3/4) Key Business Segments Healthcare Services

Key Geographic Segments Pharmacy

Others

100% 50% 0%

India 100%

72.7%

70.0%

67.4%

68.9%

50%

25.2% 2.1% 27.1% 2.9% 29.0% 3.6% 31.1%

2011

2012

2013

2014

100%

India is the only geographic segment in which the publicly listed company operates

0% 2014

Business Highlights Description

News

Overview

• XX

Pharmacy Retail

• XX

Acquisition

• XX

Future Plans

• XX PHARMACY RETAIL MARKET IN INDIA 2015.PPT

23

Public: Domestic Company – Company A (4/4)

•X

•X

S

W

O

T

•X

•X

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

24

Private: Domestic Company – Company B (1/5) Company Information Corporate Address

X

Tel No.

X

Fax No.

X

Website

X

Year of Incorporation

X

Offices and Centres – India

Kolkata

Products and Services Category

Products/Services

X

X

Head Office

Key People

X

X

X

X

Name

Designation

X

X

X

X

X

X

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

25

Private: Domestic Company – Company B (1/5) Shareholders of the Company Name

Ownership Structure No. of Shares held

Bodies corporate Directors or relatives of directors

X

82,739

X

78,400

X

52,500

X

39,000

X

36,000

X

3,449,861 Total

Other top 50 shareholders

26.5%

0.4%

3,738,500 73.1%

Ownership structure corresponds to Date of AGM: 10/09/2014

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

26

Private: Domestic Company – Company B (3/5) Financial Snapshot

Key Ratios

Total Revenue

Net Profit/Loss

INR mn 3000

INR mn 45.0 6.8

2000 1000

Particulars

1582.9

1848.7

1.6 1997.6

-21.4

2513.9

0

50

0

-50 2011

2012

2013

2014

2011

2012

2013

2014

N.A.

N.A

N.A

N.A

Net Income Margin %

2.84%

0.37%

0.08%

-0.85%

EBITDA Margin %

18.25%

15.39%

15.39%

11.36%

N.A.

N.A

N.A

N.A

EBIT Margin %

16.95%

13.94%

13.80%

9.64%

Return on Assets %

5.16%

0.54%

0.13%

-1.44%

Return on Working Capital %

33.90%

NA

61.46%

NA

Return on Equity %

32.51%

10.63%

2.49%

-48.60%

Current Ratio

2.14

0.99

1.28

0.95

Cash Ratio

0.47

0.10

0.25

0.12

Profitability Ratios Gross Margin %

EBITA Margin %

Liquidity Ratios

Financial Summary • Company incurred a net loss of INR 21.4 mn in FY 2014, as compared to net profit of INR 1.6 mn in FY 2013

Leverage Ratios

• It reported total income of INR 2513.9 mn in FY 2014, registering an increase of 25.9 % from FY 2013

Total Debt/Equity

4.29

14.51

14.13

21.99

Total Debt/ Working Capital

1.66

NA

4.45

NA

• The company reported debt to equity of 21.99 in FY 2014, as compared to 14.13 in 2013

Interest Coverage

4.79

2.28

2.19

1.71

Total Asset Turnover

1.97

1.74

1.58

1.82

Fixed Asset Turnover

6.19

5.97

5.86

6.11

Accounts Receivable Turnover

25.69

32.87

32.05

32.63

Inventory Turnover

3.01

2.13

2.63

2.69

Efficiency Ratios

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

27

Private: Domestic Company – Company B (4/5) Business Highlights Description

News

Overview

• XX

Pharmacy Retail

• XX

Future Plans

• XX

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

28

Private: Domestic Company – Company B (5/5)

• XX

• XX

S

W

O

T

• XX

• XX

PHARMACY RETAIL MARKET IN INDIA 2015.PPT

29

Thank you for the attention Pharmacy Retail Market – India report is part of Netscribes’ Healthcare Industry Series. For any queries or customized research requirements, contact us at: Phone: E-Mail:

+91 22 4098 7600 [email protected]

About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives. Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. PHARMACY RETAIL MARKET IN INDIA 2015.PPT

30

View more...

Comments

Copyright ©2017 KUPDF Inc.
SUPPORT KUPDF